Skip to main content
. 2018 Sep 13;67(12):2507–2517. doi: 10.2337/db18-0439

Figure 3.

Figure 3

Insulin-stimulated TGD (total height of bars), nonoxidative glucose disposal (NOGD) (shaded part of bars), and glucose oxidation (GOX) in FH+ and FH individuals during the euglycemic insulin clamp performed at baseline and after 3 days of glucose infusion. Right panel shows control subjects receiving saline infusion. *P < 0.05, FH+ vs. FH; †P < 0.05, postglucose infusion vs. baseline.